156 related articles for article (PubMed ID: 32466107)
21. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
[TBL] [Abstract][Full Text] [Related]
22. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
[TBL] [Abstract][Full Text] [Related]
23. Association of Parkinson's disease with symptoms of attention deficit hyperactivity disorder in childhood.
Walitza S; Melfsen S; Herhaus G; Scheuerpflug P; Warnke A; Müller T; Lange KW; Gerlach M
J Neural Transm Suppl; 2007; (72):311-5. PubMed ID: 17982908
[TBL] [Abstract][Full Text] [Related]
24. Cardiovascular measures in children and adolescents with attention-deficit/hyperactivity disorder who are new users of methylphenidate and atomoxetine.
Arcieri R; Germinario EA; Bonati M; Masi G; Zuddas A; Vella S; Chiarotti F; Panei P;
J Child Adolesc Psychopharmacol; 2012 Dec; 22(6):423-431. PubMed ID: 23362511
[TBL] [Abstract][Full Text] [Related]
25. Pharmacotherapy May Attenuate the Risk of Child Abuse in Attention-Deficit/Hyperactivity Disorder from the Real-World Evidence.
Lin CC; Chung CH; Chien WC; Tzeng NS
J Child Adolesc Psychopharmacol; 2023 Mar; 33(2):59-68. PubMed ID: 36944094
[No Abstract] [Full Text] [Related]
26. Methylphenidate in Adults with Attention Deficit Hyperactivity Disorder and Substance Use Disorders.
Simon N; Rolland B; Karila L
Curr Pharm Des; 2015; 21(23):3359-66. PubMed ID: 26088112
[TBL] [Abstract][Full Text] [Related]
27. The effect of methylphenidate treatment on psychopathic behavior of patients having attention-deficit hyperactivity disorder with and without oppositional defiant disorder.
Golubchik P; Levy T; Weizman A
Int Clin Psychopharmacol; 2018 Nov; 33(6):330-333. PubMed ID: 29958238
[TBL] [Abstract][Full Text] [Related]
28. Age-related pharmacotherapy of attention deficit hyperactivity disorder in Slovenia in children and adolescents: A population-based study.
Stuhec M; Locatelli I
Eur Psychiatry; 2017 May; 42():129-133. PubMed ID: 28371725
[TBL] [Abstract][Full Text] [Related]
29. The use of stimulants and atomoxetine in adults with comorbid ADHD and bipolar disorder.
Perugi G; Vannucchi G
Expert Opin Pharmacother; 2015; 16(14):2193-204. PubMed ID: 26364896
[TBL] [Abstract][Full Text] [Related]
30. Comparative study of OROS-MPH and atomoxetine on executive function improvement in ADHD: a randomized controlled trial.
Yang L; Cao Q; Shuai L; Li H; Chan RC; Wang Y
Int J Neuropsychopharmacol; 2012 Feb; 15(1):15-26. PubMed ID: 22017969
[TBL] [Abstract][Full Text] [Related]
31. Improvements in Irritability with Open-Label Methylphenidate Treatment in Youth with Comorbid Attention Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder.
Winters DE; Fukui S; Leibenluft E; Hulvershorn LA
J Child Adolesc Psychopharmacol; 2018 Jun; 28(5):298-305. PubMed ID: 29708762
[TBL] [Abstract][Full Text] [Related]
32. A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.
King S; Griffin S; Hodges Z; Weatherly H; Asseburg C; Richardson G; Golder S; Taylor E; Drummond M; Riemsma R
Health Technol Assess; 2006 Jul; 10(23):iii-iv, xiii-146. PubMed ID: 16796929
[TBL] [Abstract][Full Text] [Related]
33. Attention-deficit/hyperactivity disorder and comorbid subsyndromal depression: what is the impact of methylphenidate on mood?
Golubchik P; Kodesh A; Weizman A
Clin Neuropharmacol; 2013; 36(5):141-5. PubMed ID: 24045603
[TBL] [Abstract][Full Text] [Related]
34. The risk of injury in adults with attention-deficit hyperactivity disorder: A nationwide, matched-cohort, population-based study in Taiwan.
Chien WC; Chung CH; Lin FH; Yeh CB; Huang SY; Lu RB; Chang HA; Kao YC; Chiang WS; Chou YC; Tsao CH; Wu YF; Tzeng NS
Res Dev Disabil; 2017 Jun; 65():57-73. PubMed ID: 28458048
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders.
Pringsheim T; Steeves T
Cochrane Database Syst Rev; 2011 Apr; (4):CD007990. PubMed ID: 21491404
[TBL] [Abstract][Full Text] [Related]
36. Impact of Drug Adherence on Oppositional Defiant Disorder and Conduct Disorder Among Patients With Attention-Deficit/Hyperactivity Disorder.
Wang LJ; Lee SY; Chou MC; Yang KC; Lee TL; Shyu YC
J Clin Psychiatry; 2018 Aug; 79(5):. PubMed ID: 30192445
[TBL] [Abstract][Full Text] [Related]
37. Treatment persistence in attention deficit/hyperactivity disorder: a retrospective analysis of patients initiated on lisdexamfetamine vs other medications.
Setyawan J; Guérin A; Hodgkins P; Gauthier G; Cloutier M; Wu E; Erder MH
J Med Econ; 2013 Nov; 16(11):1275-89. PubMed ID: 24004347
[TBL] [Abstract][Full Text] [Related]
38. Nationwide rate of attention-deficit hyperactivity disorder diagnosis and pharmacotherapy in Korea in 2008-2011.
Hong M; Kwack YS; Joung YS; Lee SI; Kim B; Sohn SH; Chung US; Yang J; Bhang SY; Hwang JW; Choi HY; Oh IH; Lee YJ; Bahn GH
Asia Pac Psychiatry; 2014 Dec; 6(4):379-85. PubMed ID: 25277653
[TBL] [Abstract][Full Text] [Related]
39. A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.
Kollins SH
Curr Med Res Opin; 2008 May; 24(5):1345-57. PubMed ID: 18384709
[TBL] [Abstract][Full Text] [Related]
40. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
